AstraZeneca PLC ( AZN) - Key Metrics
AZN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $9.72 | $1.62 | $3.28 | $2.84 |
| 2025Q2 | $9.58 | $1.62 | $2.18 | $0.94 |
AZN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | 63.60% | 23.20 |
| 2025Q2 | 0.40% | 21.41 |
AZN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.45% | ? |
| 2026Q1 | 1.19% | ? |
| 2025Q4 | 1.01% | ? |
| 2025Q3 | 2.92% | 0.69% |
| 2025Q2 | 1.35% | 0.00% |
AZN
Price: $171.49
Dividend Yield: 2.06%
Forward Dividend Yield: 1.23%
Payout Ratio: 48.78%
Dividend Per Share: 2.12 USD
Earnings Per Share: 6.68 USD
P/E Ratio: 25.40
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Volume: 4.8 million
Ebitda: 1.8 billionMarket Capitalization: 243.3 billion
Average Dividend Frequency: 2
Years Paying Dividends: 34
DGR3: 2.60%
DGR5: 2.27%
DGR10: -2.91%
DGR20: 7.51%